ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cytokinetics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.17
2
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(HY) At USD 47.98 MM has Grown at -29.8%
- OPERATING CASH FLOW(Y) Lowest at USD -555.45 MM
- NET PROFIT(HY) At USD -405.99 MM has Grown at -41.14%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 47.01%, its profits have fallen by -16.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cytokinetics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cytokinetics, Inc.
47.01%
0.64
45.56%
S&P 500
15.36%
1.17
13.09%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.54%
EBIT Growth (5y)
-235.20%
EBIT to Interest (avg)
-6.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.98
Sales to Capital Employed (avg)
0.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-11.67
EV to EBIT
-13.05
EV to EBITDA
-13.27
EV to Capital Employed
-21.67
EV to Sales
90.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at USD -405.99 MM
CASH AND EQV(HY)
Highest at USD 1,990.45 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 108.91 times
-21What is not working for the Company
NET SALES(HY)
At USD 47.98 MM has Grown at -29.8%
OPERATING CASH FLOW(Y)
Lowest at USD -555.45 MM
NET PROFIT(HY)
At USD -405.99 MM has Grown at -41.14%
INTEREST(HY)
At USD 68.17 MM has Grown at 44.39%
RAW MATERIAL COST(Y)
Grown by 30.13% (YoY
Here's what is working for Cytokinetics, Inc.
Net Profit
Higher at USD -405.99 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Cash and Eqv
Highest at USD 1,990.45 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 108.91 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at USD 3.63 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Cytokinetics, Inc.
Net Sales
At USD 47.98 MM has Grown at -29.8%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Net Profit
At USD -405.99 MM has Grown at -41.14%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -555.45 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Interest
At USD 68.17 MM has Grown at 44.39%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Raw Material Cost
Grown by 30.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
